http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104531629-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-01019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1074 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-60 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-07 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 |
filingDate | 2014-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104531629-B |
titleOfInvention | A kind of yclodextrin glycosyltransferase mutant of raising AA 2G conversion ratios |
abstract | The invention discloses a kind of yclodextrin glycosyltransferase mutant of raising AA 2G conversion ratios, belong to genetic engineering and enzyme engineering field.The present invention is that nearby the lysine mutation of the 228th obtains mutant K228R for arginine by the cyclodextrin glycosyltransferase activated centre of bacillus stearothermophilus (Bacillus stearothermophilus NO2), the Aspartic acid mutations of the 367th obtain mutant D367S into serine, and the double mutation of progress obtain mutant D367S/K228R on this basis.Mutant realizes the raising of AA 2G transformation efficiencies, with higher industrial value. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108384741-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108384741-A |
priorityDate | 2014-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.